Interview With Janssen Doctor Explores Potential Bladder Cancer

$ 24.50

5 (739) In stock

Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.

Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective

Advances in immunotherapies and targeted treatments for patients

/wp-content/uploads/2023/06/

Bladder Preservation Strategies for Muscle-Invasive Bladder Cancer – Patient Guide - Bladder Cancer Canada

Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer

Frontiers The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic

IJMS, Free Full-Text

Frontiers HER2 expression in urothelial carcinoma, a systematic literature review

ANZUP, A little below the belt

New ways to treat bladder cancer improve survival and shake up the standard of care, new studies show

Paige and Janssen Deploy AI Based Biomarker Test For Bladder Cancer

2023 Bladder Cancer Think Tank Meeting

What are the most common causes of bladder cancer? - Online interview